Effect of low-density lipoprotein apheresis on kinetics of apolipoprotein B in heterozygous familial hypercholesterolemia

被引:13
作者
Maugeais, C
Ouguerram, K
Frénais, R
Maugère, P
Charbonnel, B
Magot, T
Krempf, M [1 ]
机构
[1] Hotel Dieu, Clin Endocrinol, F-44093 Nantes 01, France
[2] Hotel Dieu, Ctr Rech Nute Humaine, F-44093 Nantes 01, France
关键词
D O I
10.1210/jc.86.4.1679
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The acute reduction of low-density lipoprotein (LDL) cholesterol obtained by LDL-apheresis allows the role of the high level of circulating LDL on lipoprotein metabolism in heterozygous familial hypercholesterolemia (heterozygous FH) to he addressed. We studied apolipoprotein B (apoB) kinetics in five heterozygous FH patients before and the day after an apheresis treatment using endogenous labeling with [(2)H(3)]leucine. Compared with younger control subjects, heterozygous FH patients before apheresis showed a significant decrease in the fractional catabolic rate of LDL (0.24 +/- 0.08 vs. 0.65 +/- 0.22 day(-1); P < 0.01), and LDL production was increased in heterozygous FH patients (18.9 +/- 7.0 vs. 9.9 +/- 4.2 mg/kg.day; P < 0.05). The modeling of postapheresis apoB kinetics was performed using a nonsteady state condition, taking into account the changing pool size of very low density lipoprotein (VLDL), intermediate density lipoprotein, and LDL apoB. The postapheresis kinetic parameters did not show statistical differences compared with preapheresis parameters in heterozygous FH patients; however, a trend for increases in fractional catabolic rate of LDL (0.24 +/- 0.08 vs. 0.35 +/- 0.09 day(-1); P = 0.067) and the production of VLDL (13.7 +/- 8.3 vs. 21.9 +/- 1.6 mg/ kg day; P = 0.076) was observed. These results suggested that the marked decrease in plasma LDL obtained a short time after LDL-apheresis is able to stimulate LDL receptor activity and VLDL production in heterozygous FH.
引用
收藏
页码:1679 / 1686
页数:8
相关论文
共 43 条
[1]   NO EVIDENCE FOR FEEDBACK INHIBITION OF HEPATIC APOLIPOPROTEIN-B (APO-B) PRODUCTION AFTER EXTRACORPOREAL LOW-DENSITY-LIPOPROTEIN PRECIPITATION AS DETERMINED BY [1-C-13]LEUCINE INFUSION IN NORMAL VOLUNTEERS [J].
ARENDS, J ;
BIER, DM ;
SCHAFER, G ;
ARMSTRONG, VW ;
THIERY, J ;
SEIDEL, D ;
SCHAUDER, P .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1993, 23 (10) :602-614
[2]   Low-density lipoprotein-apolipoprotein B metabolism following apheresis: Simulation studies of mass changes and tracer kinetics [J].
Barrett, PHR ;
Parhofer, KG .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1998, 47 (04) :478-483
[3]  
BELTZ WF, 1990, J LIPID RES, V31, P361
[4]  
BOSTROM K, 1988, J BIOL CHEM, V263, P4434
[5]   A RECEPTOR-MEDIATED PATHWAY FOR CHOLESTEROL HOMEOSTASIS [J].
BROWN, MS ;
GOLDSTEIN, JL .
SCIENCE, 1986, 232 (4746) :34-47
[6]  
CIANFLONE KM, 1990, J LIPID RES, V31, P2045
[7]   TRACER-TO-TRACEE RATIO FOR ANALYSIS OF STABLE ISOTOPE TRACER DATA - LINK WITH RADIOACTIVE KINETIC FORMALISM [J].
COBELLI, C ;
TOFFOLO, G ;
FOSTER, DM .
AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 262 (06) :E968-E975
[8]   MEASUREMENT OF VERY LOW-DENSITY AND LOW-DENSITY-LIPOPROTEIN APOLIPOPROTEIN (APO)-B-100 AND HIGH-DENSITY-LIPOPROTEIN APO-A-I PRODUCTION IN HUMAN-SUBJECTS USING DEUTERATED LEUCINE - EFFECT OF FASTING AND FEEDING [J].
COHN, JS ;
WAGNER, DA ;
COHN, SD ;
MILLAR, JS ;
SCHAEFER, EJ .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (03) :804-811
[9]   INCREASED HEPATIC SECRETION OF VERY-LOW-DENSITY-LIPOPROTEIN APOLIPOPROTEIN B-100 IN HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA - A STABLE-ISOTOPE STUDY [J].
CUMMINGS, MH ;
WATTS, GF ;
UMPLEBY, M ;
HENNESSY, TR ;
QUINEY, JR ;
SONKSEN, PH .
ATHEROSCLEROSIS, 1995, 113 (01) :79-89
[10]   Sensitive methods to study human apolipoprotein B metabolism using stable isotope-labeled amino acids [J].
Demant, T ;
Packard, CJ ;
Demmelmair, H ;
Stewart, P ;
Bedynek, A ;
Bedford, D ;
Seidel, D ;
Shepherd, J .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 1996, 270 (06) :E1022-E1036